IPO7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.30350000004942E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.66028999999401E-05 |
Normal-vs-Stage2 |
3.277000E-03 |
Normal-vs-Stage3 |
1.01600000002033E-06 |
Normal-vs-Stage4 |
8.4905000000024E-05 |
Stage1-vs-Stage2 |
8.052200E-01 |
Stage1-vs-Stage3 |
6.402200E-02 |
Stage1-vs-Stage4 |
2.341800E-01 |
Stage2-vs-Stage3 |
3.524200E-01 |
Stage2-vs-Stage4 |
5.160200E-01 |
Stage3-vs-Stage4 |
8.762600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.67491999999436E-05 |
Normal-vs-AfricanAmerican |
6.25520002461855E-09 |
Normal-vs-Asian |
4.967800E-01 |
Caucasian-vs-AfricanAmerican |
3.476900E-03 |
Caucasian-vs-Asian |
3.554600E-01 |
AfricanAmerican-vs-Asian |
3.169700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.79149999996109E-06 |
Normal-vs-Female |
4.33360000107186E-08 |
Male-vs-Female |
1.915960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.062670E-03 |
Normal-vs-Age(41-60Yrs) |
1.88788999999634E-05 |
Normal-vs-Age(61-80Yrs) |
2.11299999997028E-06 |
Normal-vs-Age(81-100Yrs) |
4.61419999997492E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.766200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.393400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.653000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.279400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.734400E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.947600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.942200E-02 |
Normal-vs-Grade 2 |
1.566010E-04 |
Normal-vs-Grade 3 |
6.18850000133619E-08 |
Normal-vs-Grade 4 |
1.199190E-04 |
Grade 1-vs-Grade 2 |
8.585000E-01 |
Grade 1-vs-Grade 3 |
6.341400E-01 |
Grade 1-vs-Grade 4 |
4.585400E-01 |
Grade 2-vs-Grade 3 |
7.079700E-02 |
Grade 2-vs-Grade 4 |
1.708810E-01 |
Grade 3-vs-Grade 4 |
7.001400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.005300E-04 |
Normal-vs-ccB subtype |
9.84769999999857E-05 |
ccA subtype-vs-ccB subtype |
2.903200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.70579999994691E-06 |
Normal-vs-N1 |
1.071590E-01 |
N0-vs-N1 |
9.045400E-01 |
|
|